QUEBEC CITY,
Nov. 3, 2011 /PRNewswire/ - Aeterna
Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company")
will report its third quarter 2011 financial and operating results
on Thursday, November 10, 2011. The
Company will host a conference call and webcast to discuss these
results later that same day at 10:00 a.m.,
Eastern Time.
Participants may access the live webcast via the
Company's website at www.aezsinc.com in the "Newsroom" section, or
by telephone using the following numbers: in Canada 514-807-8791 or 416-644-3424, outside
Canada, 800-594-3790. A replay of
the webcast will also be available on the Company's website for a
period of 30 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a late-stage oncology drug
development company currently investigating potential treatments
for various cancers including colorectal, multiple myeloma,
endometrial, ovarian, prostate and bladder cancer. The Company's
innovative approach of "personalized medicine" means tailoring
treatments to a patient's specific condition and to unmet medical
needs. Aeterna Zentaris' deep pipeline is drawn from its
proprietary discovery unit providing the Company with constant and
long-term access to state-of-the-art therapeutic options. For more
information please visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.